We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Inhaled Insulin Combination Product
FDA Approves First Inhaled Insulin Combination Product
February 3, 2006
The FDA has approved Pfizer’s inhaled insulin product, Exubera, for the treatment of Type 1 and Type 2 diabetes.